<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="3962">Curcumin</z:chebi> has promising potential in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevention and therapy by interacting with proteins and modifying their expression and activity, which includes transcription factors, inflammatory cytokines and factors of cell survival, proliferation and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>miR-21 is overexpressed in many <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, promoting progression and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study, we examined the potential of <z:chebi fb="0" ids="3962">curcumin</z:chebi> to regulate miR-21, <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e>, invasion and in vivo <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In Rko and HCT116 cells, we identified two new transcriptional start sites of the miR-21 gene and delineated its promoter region </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="1" ids="53780">PMA</z:chebi> stimulation induced miR-21 expression via motifs bound with AP-1 (activator protein 1) transcription factors </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="3962">Curcumin</z:chebi> treatment reduced miR-21 promoter activity and expression in a dose-dependent manner by inhibiting AP-1 binding to the promoter, and induced the expression of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor Pdcd4 (programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> protein 4), which is a target of miR-21 </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="3962">Curcumin</z:chebi>-treated Rko and HCT116 cells were arrested in the G2/M phase with increasing concentrations </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, <z:chebi fb="0" ids="3962">curcumin</z:chebi> inhibited <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e>, invasion and in vivo <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in the chicken-embryo-<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> assay [CAM (chorionallantoic membrane) assay] </plain></SENT>
<SENT sid="8" pm="."><plain>Additionally, <z:chebi fb="0" ids="3962">curcumin</z:chebi> significantly inhibited miR-21 expression in <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumours</z:e> generated in vivo in the CAM assay by Rko and HCT116 cells (P&lt;0.00006 and P&lt;0.035 respectively) </plain></SENT>
<SENT sid="9" pm="."><plain>Taken together, this is the first paper to show that <z:chebi fb="0" ids="3962">curcumin</z:chebi> inhibits the transcriptional regulation of miR-21 via AP-1, suppresses cell proliferation, <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e>, invasion and in vivo <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, and stabilizes the expression of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor Pdcd4 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>